ADVERTISEMENT
Emami Q4 Results Review: Dolat Capital Maintains 'Reduce' After Recent Stock Run-Up, But Hikes Target Price
Valuing Emami at 30x FY27E EPS, Dolat Capital has increased its target price at Rs 656 and considering the recent run-up in the stock price, retains ‘Reduce’ rating.
19 May 2025, 10:28 AM IST 
Emami's net sales grew by 8.1% YoY to Rs 9.6 billion in Q4 FY25, in line with estimates. (Photo source: Company website)
Urban demand faced challenges due to food inflation and liquidity issues, while rural demand remained resilient, driven by favorable monsoons and a strong harvest, offering a positive outlook amidst market uncertainties. Emami's new launches and brand investment helped Navratna and Dermicool/ Healthcare/ Boroplus/ Pain management/ Male grooming to report 16/13/27/1/7% growth during the quarter.
I’m already a Subscriber
To continue reading this storySubscribe to Unlock & Enjoy your
Subscriber-Only benefits
Subscriber-Only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Subscriber-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Subscriber-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
